PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PMCB

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	22 : 00	Business Wire	PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease	NASDAQ:PMCB	PharmaCyte Biotech Inc
2024/02/15	05 : 38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PMCB	PharmaCyte Biotech Inc
2024/02/06	23 : 56	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/12/16	07 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/29	07 : 06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/25	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/23	06 : 00	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/15	22 : 30	Business Wire	PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/11/10	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/31	22 : 15	Business Wire	PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/31	22 : 15	Business Wire	PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/10/02	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/22	06 : 04	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/18	19 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/16	06 : 00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/12	10 : 56	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/09/08	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/05	05 : 40	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/05	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/01	06 : 18	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/08/01	05 : 42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/07/19	23 : 28	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/06/17	06 : 23	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PMCB	PharmaCyte Biotech Inc
2023/06/16	05 : 02	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	NASDAQ:PMCB	PharmaCyte Biotech Inc